Format

Send to

Choose Destination
See comment in PubMed Commons below
Diab Vasc Dis Res. 2008 Mar;5(1):59-66. doi: 10.3132/dvdr.2008.011.

Blocking the renin-angiotensin-aldosterone system to prevent diabetes mellitus.

Author information

  • 1Department of Internal Medicine, the University of Texas Southwestern Medical Center, Dallas, Texas, USA. darren.mcguire@utsouthwestern.edu

Abstract

Type 2 diabetes mellitus (DM) is increasing around the world, and the public health impact of DM, driven largely by cardiovascular disease complications, underpins the importance of continued efforts toward primary prevention of DM. Only a few interventions have been shown to prevent DM, with none of them yet proven to improve cardiovascular risk commensurately. Accumulating evidence suggest that drugs that block the renin-angiotensin-aldosterone system (RAAS), many of which have proven cardiovascular disease (CVD) benefit, also have favourable effects on parameters of glucose metabolism and incident diabetes. Here we review the evidence accumulated to date from animal studies, clinical mechanistic studies and clinical trials regarding the effect of RAAS inhibition and incident DM.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Write to the Help Desk